142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

307489
Agenda-Setting for Expanded Policy-Driven Change: Research Directions for Leadership and Practice Development to Improve Population Health

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014 : 12:50 PM - 1:10 PM

Charles (Chuck) T. Kozel, PhD, MPH, MCHES , Public Health Sciences Department, New Mexico State University, Las Cruces, NM
Michael Hatcher, DrPH , Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, GA
Anne Hubbell, PhD , Department of Communication Studies, New Mexico State University, Las Cruces, NM
Background:  This research provides novel directions for addressing health disparities through the diffusion of policy-driven health promotion innovations. How public policy decision makers choose which issues are important has been the subject of much research.  Agenda-setting theorists postulate that mass media do not determine what people think but influence what they talk about. Agenda-setting offers explanation of how issues move from relative unimportance to the forefront of action among the media, public, and policymakers. Methods:  A bi-national interdisciplinary research team examined agenda-setting processes and how the health agenda in the Paso del Norte region is determined. The research helped in identifying deficiencies in the border area’s public health systems, infrastructure, and channels for working toward the bi-national objectives in the Healthy Border 2010 initiative. Structured face-to-face interviews were conducted among sometimes “hidden” population of border region agenda-setters from Las Cruces, NM, El Paso, TX and Cuidad Juarez, Mexico. Each participant represented media, public, or policy affiliation. Results:  Deficiencies were specified in the border public health systems, infrastructure and channels for working toward the bi-national objectives in the Healthy Border 2010 initiative. Strategies were found including developing a shared vision, alternative solutions, pre-decision systems, and strategic collaborative partnerships for increasing media “salience” for “sustained’ action. Conclusions:  Leadership and practice implications were identified between all 3 cities for innovative Health Promotion Agenda-setting.  Findings indicate Health Promotion Agenda-Setting (HPA-S) is a subset of agenda-setting research, which provides leaders and practitioners with a framework, and strategic direction to set agendas for sustained courses of action to improve population health.

Learning Areas:

Administration, management, leadership
Public health or related education
Public health or related public policy
Public health or related research

Learning Objectives:
Describe health promotion research and practice characteristics of agenda-setting for policy driven change Discuss innovative Health Promotion Agenda-Setting (HPA-S) research and practice implications to eliminate health disparities e.g. chronic diseases, violence and intended injuries Differentiate the various uses of expanded practice strategies to foster policy-driven change to reduce chronic diseases and intended injuries

Keyword(s): Health Promotion and Education, Policy/Policy Development

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: My accomplishments include research and numerous peer review articles on public health education and health promotion leadership, and policy development at the local, state, national and international levels. Among my research interests I have been developing strategies to foster leadership and practice development for health promotion and public health policy. I serve as the Society for Public Health Education (SOPHE) Board Trustee for Professional Preparation, undergraduate and graduate levels, and I have received national recognition.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.